TE_36
Basic information Differential Expression Stage analysis Survival analysis Correlation analysis| TE family | LTR18B |
|---|---|
| TE superfamily | ERV3 |
| TE class | LTR |
| Gene | CFAP74 |
| Class | Chimeric |
| Coding | Non-coding, Other |
| Tumor-specific score | 0.31 |
| Counts of samples | TCGA_tumor:65; TCGA_normal:5; GTEx:232 |
| TSS | chr1(-):1989428 |
Transcript isoforms
| Transcript_ID | Gene | Class | Coding | ORF | Position |
|---|---|---|---|---|---|
| teRNA_36.11 | CFAP74 | Chimeric | Non-coding | Non-coding | chr1(-):1985092,1985112,1985339,1985490,1986937,1987035,1988512,1988655,1988889,1988923,1989267,1989429 |
| teRNA_36.12 | CFAP74 | Chimeric | Non-coding | Non-coding | chr1(-):1988113,1988133,1988512,1988655,1988889,1988923,1989267,1989429 |
1
2
GTEx
The proportion of samples in which the TE-initiated transcript was expressed across 46 body sites in the Genotype-Tissue Expression (GTEx) project.
TCGA
The proportion of samples in which the TE-initiated transcript was expressed across 33 cancer types from The Cancer Genome Atlas (TCGA).
GTEx
The expression of TE-initiated transcript across 46 body sites from The Genotype-Tissue Expression (GTEx) project.
